Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7 Neoplasms 2 Weight Loss 1 Prostatic Neoplasms 1 Polyps 1 Osteoporosis 1 Myocardial Ischemia 1 Myocardial Infarction 1 Metabolic Syndrome 1 Heart Diseases 1 Diabetes Mellitus 1 Depression 1 Coronary Disease 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Cardiovascular Diseases 1 Carcinoma, Renal Cell 1 Bone Diseases 1 Body Weight Changes 1 Angina, Unstable 1 Adenoma 1

Interventions

Colonoscopy 4 Endoscopy 3 Eicosapentaenoic Acid 2 Uterine Myomectomy 1 Ursodeoxycholic Acid 1 Telemedicine 1 Suppositories 1 Sennosides 1 Restraint, Physical 1 Propofol 1 Narrow Band Imaging 1 Midazolam 1 Metoclopramide 1 Folic Acid 1 Fentanyl 1 Erythromycin 1 Diet, Fat-Restricted 1 Diet 1 Diatrizoate Meglumine 1 Colonography, Computed Tomographic 1 Clinical Chemistry Tests 1 Cholecystectomy 1 Cholecalciferol 1 Celecoxib 1 Calcium Carbonate 1 CVD protocol 1 Bisacodyl 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Polyps × Diet, Fat-Restricted × Clear all

NCT00339625 2020-05-15

Polyp Prevention Trial

National Institutes of Health Clinical Center (CC)

Phase 3 Completed

Adenoma, Polyps

Data powered by HemOnc (CC BY 4.0) Colophon ⚡